Antibiotic And Pain Relief Cream
NDC Package 11673-770-14
Package Information
Antibiotic And Pain Relief (neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride) cream is clean the affected areaapply a small amount (equal to surface area of tip of finger) on the area 1 to 3 times daily.may be covered with a sterile bandage. This formulation utilizes a cream delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-770 and is authorized under FDA application M004.
Identification & Billing
- RxCUI: 1359360 - neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG per GM Topical Cream
- RxCUI: 1359360 - neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML / pramoxine hydrochloride 10 MG/ML Topical Cream
- RxCUI: 1359360 - neomycin (as neomycin sulfate) 0.35 % / polymyxin B (as polymyxin B sulfate) 10,000 UNT/ML / pramoxine (as pramoxine HCl) 1 % Topical Cream
- RxCUI: 1359360 - neomycin 0.35 % / polymyxin B 10,000 UNT/ML / pramoxine HCl 1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation
- 11673-770 - Antibiotic And Pain Relief
- 11673-770-14 - 1 TUBE in 1 CARTON / 14 g in 1 TUBE
- 11673-770 - Antibiotic And Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-770-14 identifies a specific commercial package of 1 tube in 1 carton / 14 g in 1 tube of Antibiotic And Pain Relief, a human over the counter drug labeled by Target Corporation. This cream is formulated for topical use and contains neomycin sulfate; polymyxin b sulfate; pramoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on January 31, 2024. The current certification is valid through December 31, 2026.
How is this Target Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673077014. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.